Placental growth factor before 11 weeks for screening of preterm preeclampsia: The <scp>PreMoM</scp> study

20250 citationsJournal Articlediamond Open Access

Authors

Rocío López Mármol · Instituto de Investigación Biosanitaria de Granada

José Alejandro Ávila Cabreja · Instituto de Investigación Biosanitaria de Granada

Teresa de Haro-Romero · Instituto de Investigación Biosanitaria de Granada

C. de Paco Matallana · Hospital Universitario Virgen de la Arrixaca

Olga Ocón‐Hernández · Instituto de Investigación Biosanitaria de Granada

Otilia Gonzalez · Instituto de Investigación Biosanitaria de Granada

Abstract

PlGF measured before 11 weeks did not improve preterm PE screening performance. Due to the small number of cases, further validation is needed. Maternal and biophysical markers remain a viable alternative when PlGF is unavailable.

Topics & Keywords

Pregnancy and preeclampsia studies Preterm Birth and Chorioamnionitis Gestational Diabetes Research and Management

UN Sustainable Development Goals

Gender equality

Publication Details

Published in: Acta Obstetricia Et Gynecologica Scandinavica

Volume 104, Issue 10, pp. 1897-1906

DOI: 10.1111/aogs.70026

Field-Weighted Citation Impact: 0.00